Does AMITRIPTYLINE Cause Malignant neoplasm progression? 24 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Malignant neoplasm progression have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 0.1% of all adverse event reports for AMITRIPTYLINE.
24
Reports of Malignant neoplasm progression with AMITRIPTYLINE
0.1%
of all AMITRIPTYLINE reports
3
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AMITRIPTYLINE?
Of the 24 reports, 3 (12.5%) resulted in death, 4 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does AMITRIPTYLINE Cause?
Toxicity to various agents (3,001)
Drug ineffective (2,344)
Completed suicide (1,678)
Off label use (1,588)
Pain (1,300)
Fall (1,216)
Hypotension (1,205)
Drug abuse (1,116)
Dizziness (1,041)
Constipation (1,035)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AMITRIPTYLINE Alternatives Have Lower Malignant neoplasm progression Risk?
AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE
AMITRIPTYLINE vs AMIVANTAMAB
AMITRIPTYLINE vs AMIVANTAMAB-VMJW
AMITRIPTYLINE vs AMLODIPINE
AMITRIPTYLINE vs AMLODIPINE BESILATE